2021. A comprehensive diagnostic offering workflow increases the rate of actionable results of the 23- and 35-gene expression profile tests for use as ancillary diagnostic tools for difficult-to-diagnose melanocytic lesions. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s79. DOI:https://doi.org/10.25251/skin.5.supp.79.